Respiratory therapy

Emphysema Foundation of America and Olympus Collaborate on Virtual Lung Health Education Series

Retrieved on: 
Thursday, July 15, 2021
Pulmonology, Health, Respiratory therapy, Chronic obstructive pulmonary disease, COPD: Journal of Chronic Obstructive Pulmonary Disease, Respiratory disease, Obstructive lung disease, COPD Awareness Month

LOS ANGELES and CENTER VALLEY, Pa., July 15, 2021 /PRNewswire/ --The Emphysema Foundation of America (EFA) and medical device corporation Olympus Corporation of the Americas will partner in providing a virtual lung health education series on chronic obstructive pulmonary disease (COPD).

Key Points: 
  • LOS ANGELES and CENTER VALLEY, Pa., July 15, 2021 /PRNewswire/ --The Emphysema Foundation of America (EFA) and medical device corporation Olympus Corporation of the Americas will partner in providing a virtual lung health education series on chronic obstructive pulmonary disease (COPD).
  • The series will feature five free virtual workshops to educate COPD patients, caregivers of COPD patients, and health care providers.
  • "The Emphysema Foundation of America is proud to serve those individuals and families suffering with emphysema and COPD," said Carrel.
  • Olympus Corporation of the Americas is headquartered in Center Valley, Pennsylvania, USA, with 5,500 employees throughout North and South America.

Tidal Medical Technologies receives FDA Emergency Use Authorization (EUA) for the use of InSee for tracking of incentive spirometers usage in treatment of respiratory conditions in COVID-19 patients.

Retrieved on: 
Wednesday, July 14, 2021
Respiratory therapy, Health, Branches of biology, Medicine, Spirometer, Spirometry, Respiratory disease, Incentive spirometer, COVID-19, Lung

FDA Emergency Use Authorization (EUA) issued for InSee, a patented device for tracking incentive spirometers compliance

Key Points: 
  • FDA Emergency Use Authorization (EUA) issued for InSee, a patented device for tracking incentive spirometers compliance
    In reaching their decision, FDA said there were no approved or cleared devices for quantitatively tracking patient usage of spirometers as an aid in treatment of respiratory conditions by patients with COVID-19 in hospital settings.
  • Incentive spirometers are used during recovery of respiratory illness to strengthen the muscles used for breathing and increase ventilation.
  • Incentive Spirometry has been used widely to help prevent pneumonia in bed-bound patients and help improve lung capacity in Respiratory patients, like COVID-19.
  • With the InSee, hospitals will have objective data and smart-monitoring to better help the prevention and treatment of respiratory conditions."

Aviv Clinics officially opens in JLT, Dubai, U.A.E

Retrieved on: 
Wednesday, July 14, 2021
Medicine, Mental processes, Cognition, Diving medicine, Hyperbaric medicine, Medical equipment, Oxygen, Respiratory therapy, Clinic

at Aviv Clinics .Those seeking the best of cutting-edge medicine will be able to receive it in Dubai and will not need to travel abroad.

Key Points: 
  • at Aviv Clinics .Those seeking the best of cutting-edge medicine will be able to receive it in Dubai and will not need to travel abroad.
  • Aviv has designed a program that is easy to understand including HBOT treatment, cognitive and physical training and nutrition.
  • Aviv Clinics focuses on brain performance and the clinic's specialty wings offer the latest advancements in assessing, treating, and improving cognitive and physical performance:
    1.
  • Aviv is excited and proud to open this first facility in Dubai and play its role in supporting the U.A.E.

Aviv Clinics officially opens in JLT, Dubai, U.A.E

Retrieved on: 
Wednesday, July 14, 2021
Medicine, Mental processes, Cognition, Diving medicine, Hyperbaric medicine, Medical equipment, Oxygen, Respiratory therapy, Clinic

at Aviv Clinics .Those seeking the best of cutting-edge medicine will be able to receive it in Dubai and will not need to travel abroad.

Key Points: 
  • at Aviv Clinics .Those seeking the best of cutting-edge medicine will be able to receive it in Dubai and will not need to travel abroad.
  • Aviv has designed a program that is easy to understand including HBOT treatment, cognitive and physical training and nutrition.
  • Aviv Clinics focuses on brain performance and the clinic's specialty wings offer the latest advancements in assessing, treating, and improving cognitive and physical performance:
    1.
  • Aviv is excited and proud to open this first facility in Dubai and play its role in supporting the U.A.E.

Global Asthma Epidemiology and Patient Flow Report 2021: Asthma Prevalence, Diagnosed, and Drug-treated Patients Forecast to 2035 - ResearchAndMarkets.com

Retrieved on: 
Tuesday, July 13, 2021
Health, General Health, Asthma, Chronic lower respiratory diseases, Pulmonology, Respiratory therapy, Medical specialties, Clinical medicine, Vocal cord dysfunction, Occupational asthma

The "Global Asthma Epidemiology and Patient Flow - 2021" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Asthma Epidemiology and Patient Flow - 2021" report has been added to ResearchAndMarkets.com's offering.
  • Global Asthma Epidemiology and Patient Flow Analysis - 2021, provides Asthma epidemiology, demographics, and patient flow.
  • The research provides population data to characterize Asthma patients, history of the disease at the population level (Asthma prevalence, Asthma incidence) and at the clinical level (from diagnosis to treated patients).
  • Demographics: Asthma patients by age group, gender
    The data from this research will help executives:
    Establish basis for Asthma market sizing, assessing market potential, and developing drug forecast models
    Identify Asthma patients segments through age groups, gender, and disease sub-types

Global Respiratory Care Devices Markets, 2015-2020 & 2021-2026: Chronic Obstructive Pulmonary Disease, Asthma, Sleep Apnea, Infectious Disease - ResearchAndMarkets.com

Retrieved on: 
Tuesday, July 13, 2021
Medical devices, Health, Medicine, Health care, Clinical medicine, Respiratory therapy, Medical equipment, Dosage forms, Intensive care medicine, Mechanical ventilation, Nebulizer, Positive airway pressure, Humidifier, Respiratory therapist

The global respiratory care devices market exhibited strong growth during 2015-2020.

Key Points: 
  • The global respiratory care devices market exhibited strong growth during 2015-2020.
  • Looking forward, the global respiratory care devices market to grow at a CAGR of around 11% during the forecast period (2021-2026).
  • Nebulizers, inhalers, positive airway pressure (PAP) devices, spirometers, humidifiers, etc., are some of the most commonly used respiratory care devices.
  • What is the structure of the global respiratory care devices industry and who are the key players?

United States Asthma and COPD Devices Market Report 2021: Prospects, Trends Analysis, Market Size and Forecasts up to 2026 - ResearchAndMarkets.com

Retrieved on: 
Friday, July 9, 2021
Medical devices, Health, Chronic lower respiratory diseases, Finance, Money, Economy, Respiratory therapy, Chronic obstructive pulmonary disease, Asthma, Market trend

The "United States Asthma and COPD Devices Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2026" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "United States Asthma and COPD Devices Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2026" report has been added to ResearchAndMarkets.com's offering.
  • The country research report on the United States asthma and COPD devices market is a customer intelligence and competitive study of the United States market.
  • Moreover, the report provides deep insights into demand forecasts, market trends, and, micro and macro indicators in the United States market.
  • 5) What are the modes of entering the United States asthma and COPD devices market?

India Oxygen Concentrators Markets 2021-2022 & 2027 by Type, Technology, Flow-rate, Source, Distribution Channel, Offering, Application, End User - ResearchAndMarkets.com

Retrieved on: 
Friday, July 9, 2021
Medical devices, Health, Chemistry, Physical sciences, Natural sciences, Industrial gases, Oxygen, Medical equipment, Oxygen concentrator, Respiratory therapy, Oxygen therapy

The India Oxygen Concentrators Market is segmented by type, technology, flow-rate, source, distribution channel, offering, application, end-user, region and company.

Key Points: 
  • The India Oxygen Concentrators Market is segmented by type, technology, flow-rate, source, distribution channel, offering, application, end-user, region and company.
  • To classify and forecast the India Oxygen Concentrators Market based on type, technology, flow-rate, source, distribution channel, offering, application, end-users, company, and regional distribution.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in the India Oxygen Concentrators Market.
  • To identify key sustainable strategies adopted by market players in the India Oxygen Concentrators Market.

Tezepelumab Regulatory Submission Accepted and Granted FDA Priority Review in the US for the Treatment of Patients with Asthma

Retrieved on: 
Thursday, July 8, 2021
Cardiology, Medical Supplies, Biotechnology, FDA, Health, General Health, Pharmaceutical, Research, Hospitals, Science, Clinical trials, Medical specialties, Clinical medicine, Medicine, Respiratory therapy, Immunology, Asthma, Monoclonal antibodies, Amgen, Tezepelumab, Thymic stromal lymphopoietin, Exhaled nitric oxide, Immunoglobulin E

These are inflammatory biomarkers used by clinicians to inform treatment options and involve tests analyzing a patients blood (eosinophils/IgE) and exhaled air (FeNO).

Key Points: 
  • These are inflammatory biomarkers used by clinicians to inform treatment options and involve tests analyzing a patients blood (eosinophils/IgE) and exhaled air (FeNO).
  • There were no clinically meaningful differences in safety results between the tezepelumab and placebo groups in the NAVIGATOR trial.
  • NAVIGATOR is the first Phase III trial to show benefit in severe asthma irrespective of eosinophils by targeting thymic stromal lymphopoietin (TSLP).
  • These results support the US Food and Drug Administration Breakthrough Therapy Designation granted to tezepelumab in September 2018 for patients with severe asthma, without an eosinophilic phenotype.

Fast-Growing Medical Equipment Provider Expands to Denver

Retrieved on: 
Thursday, July 8, 2021
Respiratory therapy, Medical device, Health care, Hospital, Ventilator, Health sciences, Health, Neonatology, Nursing, Intensive care medicine

DENVER, July 8, 2021 /PRNewswire/ --From the major medical centers of Denver to underserved rural hospitals in small mountain towns across the region, Colorado medical staff have faster access to the highest quality medical devices for patients in their care with the opening of US Med-Equip's newest branch.

Key Points: 
  • DENVER, July 8, 2021 /PRNewswire/ --From the major medical centers of Denver to underserved rural hospitals in small mountain towns across the region, Colorado medical staff have faster access to the highest quality medical devices for patients in their care with the opening of US Med-Equip's newest branch.
  • US Med-Equip (USME) is the fastest growing provider of respiratory, neonatal, infusion and other medical devices.
  • The Houston-based company partners with top hospitals across the nation in the rental, sales, service and asset management of movable medical equipment ranging from patient monitors to ventilators, newborn incubators and more.
  • USME's industry-leading technology supports hospitals' efficient use, maintenance and management of medical equipment.